The Ghana Medical Trust Fund (GMTF) has disclosed that KGL Group has committed US$10 million toward the establishment of a modern Diagnostic and Imaging Centre at the Greater Accra Regional Hospital, as part of a broader push by the Fund to address structural gaps that have long made specialised healthcare difficult to access for many Ghanaians.
According to the GMTF, this investment forms part of a wider portfolio of infrastructure projects the Trust Fund is currently supporting across the country, positioning its work as extending well beyond the simple payment of medical bills for individual patients.
Among the projects highlighted, the GMTF confirmed that new cardiac centres are currently underway at both the Komfo Anokye Teaching Hospital (KATH) and Tamale Teaching Hospital, aimed at expanding access to specialised cardiac care beyond the country’s traditional referral centres in Accra.
Alongside these cardiac projects, the Fund also disclosed that plans are progressing for a comprehensive Oncology and Nuclear Medicine Centre at Korle Bu Teaching Hospital, a facility expected to significantly strengthen Ghana’s capacity to diagnose and treat cancer using advanced nuclear medicine techniques currently limited within the country’s public health system.
KGL Group’s US$10 Million Commitment
Central to the GMTF’s latest disclosure was confirmation that KGL Group has formally committed US$10 million toward the construction of a modern Diagnostic and Imaging Centre at the Greater Accra Regional Hospital.

The Trust Fund described this investment as a significant step toward strengthening diagnostic capacity within the public health system, an area often cited as a critical bottleneck in the early detection and management of serious illnesses.
The Fund’s broader vision was shared during an engagement at SIGA, where GMTF Administrator, Adjoa Obuobia Darko-Opoku, outlined the scope of the Trust Fund’s ongoing work, covering specialist training, equipment provision and maintenance, medical research, and direct patient support, with more than 500 patients already onboarded onto the GMTF Care programme.
“What touched us most was that SIGA did not simply receive our story, they embraced it,”
GMTF
Collaboration Framed as Essential to Transformation
Reflecting on the engagement, the GMTF stressed that meaningful transformation of Ghana’s healthcare system cannot be achieved by any single institution acting alone, framing partnerships such as the one with SIGA as central to the Fund’s long-term strategy.

“Their willingness to stand with the Trust Fund reminds us that transforming healthcare cannot be the work of one institution alone,”
GMTF
Throughout its statement, the GMTF was deliberate in framing its work as extending far beyond the immediate function of covering individual medical bills for patients. Instead, the Fund positioned itself as actively engaged in building durable healthcare infrastructure and specialist capacity capable of serving Ghanaians well into the future.
“This is bigger than medical bills, it is about building a healthcare system families can depend on today, tomorrow and for generations to come,”
GMTF
Growing Portfolio of Specialised Healthcare Investment
Taken together, the combination of new cardiac centres at KATH and Tamale, the planned Oncology and Nuclear Medicine Centre at Korle Bu, and the newly disclosed US$10 million Diagnostic and Imaging Centre at the Greater Accra Regional Hospital reflects a rapidly expanding portfolio of specialised healthcare infrastructure projects being supported by the GMTF across multiple regions of the country.

With over 500 patients already benefiting directly from GMTF Care, and several major infrastructure projects still under construction or in planning stages, attention will likely turn to how quickly these various initiatives are completed and integrated into Ghana’s broader public health system, as the Trust Fund continues positioning itself as a central player in strengthening the country’s specialised healthcare capacity for the years ahead.
READ MORE: FDA Uncovers Falsified “Dr. Alfred” Capsules Laced with Sildenafil










